Thermo Fisher unveils clinical trials, manufacturing service
Thermo Fisher Scientific has launched a combined clinical trials, manufacturing, and logistics service.
The unit, called Accelerator Drug Development, is targeting biopharma customers looking to minimize contractor oversight, according to Thermo, which unveiled the new service at a tradeshow in Milan last week.
Thermo cited its ultra-cold chain facility in Bleiswijk in the Netherlands – which opened in June – packaging unit in Basel, Switzerland, and expanded logistics operation in Buenos Aires, Argentina, as core parts of the new unit’s clinical trial business.
In addition, customers will have access to its laboratory in Center Valley, Pennsylvania, according to Thermo, which said the facility will let researchers create, test, and validate innovative solutions that address common pain points across clinical trials.
Thermo also announced plans to expand its PPD clinical research business with a new bioanalytical lab in GoCo Health Innovation City in Gothenburg, Sweden.
A Thermo spokesperson told Clinical Insider, “The creation of Accelerator Drug Development was driven by the need to address the complexities and inefficiencies that often hinder the drug discovery and development process for our customers. We recognize that biopharma and biotech companies are looking for ways to streamline their processes, reduce development timelines, and improve the quality, consistency, and reliability of their projects.
“Our aim is to speed up and simplify this intricate journey. With over 80 customers and more than 200 protocols already benefiting from our combined CDMO and CRO services, there is a strong demand for integrated solutions.”
DHL deal
Thermo said its new partnership with DHL Express – which was announced this month – will play a part in the new accelerator business.
The firm explained the business will use DHL Express’ GoGreen Plus service and “invest in sustainable aviation fuel to reduce emissions from air transportation.”
The aim is to help Thermo, and by extension, its customers, reduce greenhouse gas emissions associated with global clinical research activities, such as air shipping logistics, by up to 80%.
DepositPhotos/ventanamedia